Company / Gross Profit
Doximity Gross Profit History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$514.5M
FY2024
5-year range
$303.8M / $514.5M
FY2020-FY2024
Trend
+21.1%
vs FY2023
Sector context
#55 of 95
Health Care
What the data says
At $515M, Doximity's gross profit ranks #55 of 95 in the Health Care sector. Gross Profit has increased for 5 consecutive years, from $101M in FY2019 to $515M in FY2024.
Based on SEC 10-K filings.
$515M in FY2024 with a 5-year CAGR of +38.4%.
Improved from $366M to $515M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +19.2%
- 5-Year CAGR
- +38.4%
- 10-Year CAGR
- -
Sector benchmark
#55 of 95 in Health CareTop 58% of 95This company $514.5M Sector average $1.9B
▼
-72.6% below sector average
Key checks
Key Insights
- Doximity's gross profit has grown for 5 consecutive years.
- 5-year CAGR of +38.4%, indicating consistent growth.
- In FY2024, gross profit increased 21.1% year-over-year.
- Ranks #55 out of 95 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $514.5M | +21.1% |
| FY2023 | $424.8M | +16.2% |
| FY2022 | $365.6M | +20.3% |
| FY2021 | $303.8M | +72.9% |
| FY2020 | $175.7M | +73.1% |
| FY2019 | $101.5M | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026